Interim Analysis of Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin Versus Capecitabine Alone for Pathological Stage II and III Rectal Cancer: A Randomized Multicenter Phase III Trial
Oncotarget - United States
doi 10.18632/oncotarget.8226
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 21, 2016
Authors
Publisher
Impact Journals, LLC